Daniel Bexell

12PUBLICATIONS
72CO-AUTHORS
Molecular targetsPeripheral nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 24, 2025
Repurposing statins and phenothiazines to treat chemoresistant neuroblastoma.

Katarzyna Radke, Kristina Aaltonen, Erick A Muciño-Olmos

|Jun 25, 2025
Evaluation of TRPA1 as a Therapeutic Target in MYCN-Amplified Neuroblastoma.

Alexandra Seger, Dora Adamič, Erick Muciño Olmos

|Oct 17, 2024
Early evolutionary branching across spatial domains predisposes to clonal replacement under chemotherapy in neuroblastoma.

Jenny Karlsson, Hiroaki Yasui, Adriana Mañas

|Oct 28, 2022
Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance.

Adriana Mañas, Kristina Aaltonen, Natalie Andersson

|Oct 12, 2022
Engineering human mini-bones for the standardized modeling of healthy hematopoiesis, leukemia, and solid tumor metastasis.

Ani Grigoryan, Dimitra Zacharaki, Alexander Balhuizen

|Sep 24, 2020
Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma.

Karin Hansson, Katarzyna Radke, Kristina Aaltonen

Pageof 2